December 6, 2013 - We expect a lot of attention dedicated to large molecules and their potential for treating blood diseases at ASH this year. Particularly for certain types of lymphoma and leukemia.
Large molecule – or biologic – medicines include antibodies, fusion proteins, and antibody-drug conjugates. We’re proud to have pioneered the use of genetic engineering to make medicine, and we’re excited to continue creating innovative biologics to treat diseases like blood cancer.
See our approach to large molecule drug discovery.